F

Fraser Health

Public health authority operating hospitals

Youth Therapist - Substance Use Services

Part-TimeDeadline 9/2/27
CA$44.85 - CA$56.02/hr
Mid
Master's
Chilliwack, BC, Canada
In Person
Medical, Clinical & VeterinaryMental & Behavioral Health

About the job

Requirements
  • A Master's Degree in an applicable social or health sciences program, such as Counselling Psychology or Social Work.
  • One year of recent, related experience with youth in a mental health or substance use setting, or two years of recent related experience working with clients and families with, or affected by, mental illness and substance use disorders, or an equivalent combination of education, training and experience.
  • Eligibility for registration with the relevant applicable professional association.
  • A valid British Columbia driver's license and access to a personal vehicle for work-related purposes.
  • Knowledge of harm reduction, trauma-informed and recovery-oriented approaches, concurrent disorders, addictions, and addictions counselling.
  • Knowledge of relevant legislation, including the Mental Health Act, Freedom of Information Act, and Child, Family and Community Service Act, along with pertinent regulations, policies, procedures, and statutory duties.
  • Knowledge of psychiatric diagnosis and professional practice guidelines for treating various disorders.
  • Ability to use standardized mental health and addictions tools for client assessments.
  • Therapeutic skills in case management and individual and group therapy with youth experiencing various mental health disorders, including concurrent disorders.
  • Knowledge of issues pertaining to adolescent mental health problems.
  • Knowledge of individual developmental stages, family life cycles, and psychosocial issues.
  • Knowledge of community resources and ability to collaborate with community partners to support referrals.
  • Ability to communicate verbally and in writing within a diverse and multicultural community.
  • Ability to work with individuals, groups, and interdisciplinary professionals while understanding other disciplines' frameworks.
  • Ability to assess, plan, organize, implement, evaluate, problem-solve, and prioritize workload in a complex environment.
  • Ability to develop, coordinate, and deliver in-services, education, presentations, psycho-educational and support groups, and consultations to clients, families, and healthcare professionals.
  • Therapeutic skills in case management and individual and group therapy with adults experiencing various mental disorders, including concurrent disorders.
  • Proficiency with personal computers, word-processing software, and database-management software.
  • Physical ability to perform the duties of the position.
Responsibilities
  • Screen referrals from healthcare providers, agencies, family members, and caregivers concerning children and youth with mental health disorders and addictions, and determine appropriate treatment based on client needs, urgency, and best practices. For assigned Indigenous portfolios, conduct outreach and assertive case-finding with Indigenous communities across the Fraser Salish Region.
  • Assess client needs by gathering history and other information, conducting initial assessments of mental health status and risk, determining care priority, eligibility, resource availability, and service priorities, collaborating with the interdisciplinary team on care, and assessing the need for emergency crisis intervention.
  • Provide first-level interventions and support, including brief interventions, follow-up, monitoring, and evaluation of treatment outcomes.
  • Provide treatment, support, and case management in complex situations, including crises, through individual and group therapy for clients and families; develop recovery-oriented treatment options and plans with clients and natural supports; and provide case consultation and follow-up on treatment decisions with interdisciplinary team members.
  • Facilitate use of community services and rehabilitative programs by considering client motivation and stage of treatment, researching services, liaising with providers, advising colleagues, and making referrals as needed.
  • Refer clients to community treatment alternatives and services, including residential programs, family therapy, marital and separation counselling, alcohol and drug treatment, victim assistance, employee assistance programs, clubhouses, transition homes, vocational programs, and other agencies; use community resources to develop supportive and rehabilitative programs for clients and families.
  • Educate clients and families using evidence-based theoretical models by exploring factors contributing to substance use and mental health symptoms, identifying goals and support resources, explaining mental health and substance-use issues and recovery, suggesting positive behaviour changes, examining motivation for change, and teaching relapse-prevention strategies.
  • Provide short-term counselling, support, and education to families, caregivers, health providers, and the public about the condition, treatment, and prognosis of youth; explain coping methods and provide information about Mental Health and Substance Use Services, intake procedures, and available community and service resources.
  • Maintain client records, including assessments and charting in PARIS and other clinical information systems; prepare progress notes and reports according to applicable standards and regulatory requirements; document for future reference; and ensure information access and disclosure comply with the Freedom of Information Act.
  • Follow health and safety requirements and immediately report unsafe situations to a supervisor or other appropriate personnel.
  • Build relationships with facilities and community resources, and advocate for clients to improve access, integration, and coordination of mental health services by maintaining communication with physicians, consulting psychiatrists, colleagues, community mental health services, acute hospitals, community agencies, and other healthcare professionals.
  • Maintain data and statistics on intakes, requests, referrals, priority, sources, and nature of requests, and provide input to the Coordinator and Manager.
  • Provide consultation and knowledge exchange to Mental Health and Substance Use Services staff and external organizations, including Child and Youth Mental Health, community agencies such as Foundry, and providers serving youth with concurrent disorders; organize or participate in workshops and mutual forums; and develop or deliver educational sessions by determining content and handouts, conducting literature searches, and planning and coordinating seminars.
  • Recommend policies, processes, and procedures to improve client- and family-centred practices; develop and evaluate clinical protocols, identify service needs, and provide input and recommendations to the Coordinator or designate and Manager.
  • Participate in team planning, meetings, committees, and corporate initiatives by discussing issues, presenting relevant material, advocating for program goals, and promoting support for clients, families, and caregivers.
  • Maintain current mental health and substance-use practice by reviewing literature and research, consulting clinical and community experts, evaluating clinical practice, and participating in professional development, in-services, and case conferences.
  • Perform other related duties as assigned.

About the company

Fraser Health is a health authority in British Columbia that provides a wide range of medical services to about 1.8 million people. It operates 12 hospitals, including major trauma centres, plus an outpatient care and surgery centre, and offers residential care, home health, public health, and mental health services. The organization employs over 40,000 staff, medical professionals, and volunteers who run clinics, care centres, and community programs. Its goal is to deliver accessible, high-quality care across the network while creating good workplaces for its employees and volunteers.

Company Size

10,001+

Company Stage

Grant

Total Funding

$20K

Headquarters

Surrey, Canada

Founded

2001

Get referred to Fraser Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • The $18 million Mission Memorial ED expansion started construction in February 2026.
  • The Cloverdale UPCC opened January 28, 2026, with capacity for 64,000 annual visits.
  • Fraser Health won $1.3 million in March 2026 to expand Indigenous elder home care in Chilliwack.

What critics are saying

  • Mission Memorial ED faced repeated overnight shutdowns in May, June, and August 2026.
  • Physician staffing gaps still force service interruptions, signaling fragile emergency coverage across the network.
  • The Cloverdale hospital slipped from 2027 to 2030, weakening growth and credibility.

What makes Fraser Health unique

  • Fraser Health runs 12 hospitals and serves 1.8 million people across British Columbia.
  • Its Mission ED expansion adds 35% more space and reaches 41 care spaces by spring 2027.
  • Deloitte-backed AI scheduling models forecast patient surges and staffing demand across Fraser Health.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Paid Vacation

Growth & Insights and Company News

Headcount

6 month growth

11%

1 year growth

11%

2 year growth

11%
StockTitan
Mar 24th, 2026
Arch Biopartners and the Fraser Health Authority enter into a Clinical Trial Agreement for the Phase II cardiac surgery-associated AKI trial.

Arch Biopartners and the Fraser Health Authority enter into a Clinical Trial Agreement for the Phase II cardiac surgery-associated AKI trial. Rhea-AI Impact Rhea-AI Sentiment Rhea-AI summary. Arch Biopartners (OTCQB: ACHFF) announced a Clinical Trial Agreement with Fraser Health Authority to prepare Royal Columbian Hospital for recruitment in its Phase II trial of LSALT peptide for prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). Royal Columbian Hospital is now the ninth global site activated and the fourth Canadian recruiting site, after Toronto General Hospital, St. Michael's Hospital, and University of Calgary. Positive. * Royal Columbian Hospital received final Research Ethics Board and operational approvals * Royal Columbian Hospital became the 9th global site activated in the Phase II CS-AKI trial * 4 Canadian sites are actively recruiting patients (Toronto General, St. Michael's, Calgary, RCH) Negative. 03/24/2026 - 09:13 AM TORONTO, March 24, 2026 (GLOBE NEWSWIRE) - Arch Biopartners Inc. ("Arch" or the "Company") (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Fraser Health Authority has entered into a Clinical Trial Agreement ("CTA") with Arch to enable the Royal Columbian Hospital (RCH) to begin preparing for the recruitment phase in Arch's ongoing Phase II trial evaluating LSALT peptide for the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). With the Clinical Trial Application (CTA) completed, RCH has now received final Research Ethics Board and operational approvals, including the final letter of authorization from Fraser Health. RCH will be the ninth site activated globally in the study and will be the fourth site to recruit patients in Canada. Toronto General Hospital, part of University Health Network, St. Michael's Hospital, part of Unity Health Toronto, and the University of Calgary, Cumming School of Medicine, continue to actively enroll new patients into the trial. The Company is currently progressing feasibility and start-up discussions with additional leading cardiac surgery centres in Canada and the United States. About Arch Biopartners Arch Biopartners Inc. is a therapeutic biotech company developing novel drugs for acute kidney injury (AKI) and chronic kidney disease (CKD). The Company is advancing an integrated program that includes new treatments targeting inflammation- and toxin-related kidney injury. Arch's development pipeline includes: * LSALT peptide: in a Phase II trial targeting cardiac surgery-associated AKI. * Cilastatin: a repurposed drug in a Phase II trial targeting toxin-induced AKI. * CKD Platform: next-generation therapeutics targeting chronic kidney disease. These assets represent distinct, mechanism-based approaches to treating and preventing common causes of kidney damage. Together, they target serious unmet needs in kidney care across both chronic and acute indications, affecting more than 800 million people worldwide[1]. Both lead programs are currently enrolling patients at Canadian clinical sites, with additional North American sites in development. For more details about the Company's science and ongoing clinical trials, please visit: www.archbiopartners.com/our-science Follow Arch on LinkedIn, Bluesky, and X (formerly Twitter) for scientific insights and industry news. The Company has 66,933,289 common shares outstanding. | Aaron Benson Director of Communications Arch Biopartners, Inc. 647-428-7031 | / | | / | / | Send a message or subscribe for trial updates and company news at www.archbiopartners.com/contact-us Forward-Looking Statements This press release contains forward-looking statements within the meaning of applicable Canadian securities laws regarding expectations of the Company's future performance, liquidity, and capital resources, as well as the ongoing development of its drug candidates targeting chronic kidney disease and the dipeptidase-1 (DPEP-1) pathway, including the outcome of its clinical trials relating to LSALT peptide (Metablok) or cilastatin, the successful commercialization and marketing of its drug candidates, whether the Company will receive, and the timing and costs of obtaining, regulatory approvals in Canada, the United States, Europe, and other countries, its ability to raise capital to fund its business plans, the efficacy of its drug candidates compared to the drug candidates developed by competitors, its ability to retain and attract key management personnel, and the breadth of, and its ability to protect, its intellectual property portfolio. These statements are based on management's current expectations and beliefs, including certain factors and assumptions, as described in the Company's most recent annual audited financial statements and related management discussion and analysis under the heading "Business Risks and Uncertainties". As a result of these risks and uncertainties, or other unknown risks and uncertainties, the actual results may differ materially from those contained in any forward-looking statements. The words "believe", "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect", and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The Company undertakes no obligation to update forward-looking statements, except as required by law. Additional information relating to Arch Biopartners Inc., including the Company's most recent annual audited financial statements, is available by accessing the Canadian Securities Administrators' System for Electronic Document Analysis and Retrieval ("SEDAR") website at www.sedarplus.ca. References: * Mark, Patrick B et al. Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet, 2025;406(10518), 2461 - 2482. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01853-7/fulltext The scientific and medical content of this release has been reviewed and approved by the Company's Chief Science Officer. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Faq. What does the Clinical Trial Agreement with Fraser Health mean for Arch Biopartners (ACHFF)? It enables Royal Columbian Hospital to prepare for patient recruitment in the Phase II CS-AKI trial. According to the company, RCH now has final Research Ethics Board and operational approvals plus a letter of authorization from Fraser Health, supporting site activation. How many sites are active in Arch Biopartners' (ACHFF) Phase II LSALT CS-AKI trial after Royal Columbian Hospital activation? Royal Columbian Hospital is the ninth site activated globally in the study. According to the company, RCH is also the fourth site in Canada to reach activation and prepare for recruitment. Which Canadian hospitals are currently recruiting for Arch Biopartners' (ACHFF) Phase II CS-AKI trial? Toronto General Hospital, St. Michael's Hospital, University of Calgary, and now Royal Columbian Hospital are recruiting. According to the company, those four Canadian centres are actively enrolling new patients into the trial. What approvals did Royal Columbian Hospital receive to start recruitment for the ACHFF Phase II trial? RCH received final Research Ethics Board and operational approvals plus a letter of authorization from Fraser Health. According to the company, these approvals complete site readiness for recruitment and study start-up activities. Will Arch Biopartners (ACHFF) add more sites in Canada and the US for the Phase II CS-AKI trial? The company is progressing feasibility and start-up discussions with additional cardiac surgery centres in Canada and the United States. According to the company, those discussions aim to expand site activation beyond the current nine global sites.

Black Press Media
Mar 14th, 2026
$1.3M funding will help more Indigenous elders in Chilliwack with at-home care

$1.3M funding will help more Indigenous elders in Chilliwack with at-home care. Published 8:45 am Saturday, March 14, 2026 An at-home program that offers care to Indigenous elders in the Fraser Valley will be expanding, with the main focus on Chilliwack, thanks to $1.3 million in new funding. The Indigenous Caregiver Support Model (ICSM) is a home-based program that supports elders with "complex needs to age safely at home and in their community," according to a Fraser Health press release. It is one of five programs in B.C. benefitting from a total of $6.3 million in funding from Health Research BC over the next three years. The funding will advance research to help B.C. seniors age comfortably in their own home. The ICSM program was launched in 2023 as a pilot project and has supported 33 elders and their caregivers in the Eastern Fraser Valley, including Chilliwack. Its aim is to reduce caregiver strain and improve elder wellbeing by providing culturally safe, coordinated in-home support, training, and financial assistance for Indigenous families caring for elders. It is co-designed by Fraser Health Indigenous Health, Stó:lō Service Agency, First Nations Health Authority, and Métis Nation British Columbia. "This model is an example of what is possible when care is built on relationships, trust and community," said Amanda LaBoucane, interim vice president, Indigenous Health and Cultural Safety. "Many elders and caregivers in the Chilliwack area have experienced firsthand the impacts of residential schools and the child welfare system. By strengthening caregiver capacity and confidence while bridging into integrated clinical care teams run by and for Indigenous people, we see improved health and wellness and stronger relationships within and between communities." The program is currently operating in the Fraser Valley, including Chilliwack, but the expansion will focus on urban Chilliwack as that is an identified need, said Carrie Stefanson with Fraser Health. Caregivers receive skills training and an honorarium to help reduce the economic strain of caregiving, while elders receive regular home visits from Indigenous-led clinical teams who provide culturally safe, relationship-based care, rooted in trust, kindness and respect, according to a Fraser Health.

Fraser Health
Sep 12th, 2024
Leveraging artificial intelligence to assist with scheduling

Fraser Health has partnered with Deloitte Canada to develop and launch scheduling tools that leverage artificial intelligence (AI) and machine-learning solutions to accurately forecast the waves in demand Fraserhealth see in the health system.

Government of British Columbia
Aug 22nd, 2024
Permanent supportive, complex-care homes open in Fraser Valley

For people not already connected to services, Fraser Health will work in partnership with Coast Mental Health to provide on-site clinical supports, including services from a psychiatric nurse, community nurse, licensed practical nurse, social worker and traditional wellness practitioners.

Daily Hive
Sep 12th, 2023
Construction begins on Surrey's new $2.9 billion Cloverdale hospital

Through a procurement process, Fraser Health has selected Ellis-Don Design Build to design and build the new facility through a design-build agreement.